MIR3155A

Across TCGA pan-cancer cohorts, MIR3155A RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR3155A’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where MIR3155A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3155A is over-expressed in tumor, although a few such as PAAD and KICH show the opposite, repressed pattern.

HNSC, KIRC, and PAAD are the cancer types where MIR3155A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3155A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.209	.004	5	view →
KIRC	Male	All	+0.153	.002	4	view →
PAAD	Male	All	−0.889	.004	2	view →
KICH	All	All	−0.180	.019	2	view →
LIHC	Male	All	+0.131	.022	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR3155A–HNSC

Open the HNSC breakdown →